Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

CROCS, INC.

(CROX)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Crocs, Inc. : The technical configuration is positive

09/21/2021 | 02:37am EDT
long trade
Stop-loss triggered
Entry price : 152.84$ | Target : 180$ | Stop-loss : 135$ | Potential : 17.77%
Shares in Crocs, Inc. show a positive technical chart pattern over the medium term, which suggests that the rising trend should be followed.
Investors have an opportunity to buy the stock and target the $ 180.
Crocs, Inc. : Crocs, Inc. : The technical configuration is positive
Summary
  • The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
  • The company presents an interesting fundamental situation from a short-term investment perspective.

Strengths
  • The prospective high growth for the next fiscal years is among the main assets of the company
  • The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.
  • Margins returned by the company are among the highest on the stock exchange list. Its core activity clears big profits.
  • Over the last twelve months, the sales forecast has been frequently revised upwards.
  • Growth remains a strong point in this company. In their sales forecast, analysts sound optimistic with regard to sales prospects.
  • For the past year, analysts covering the stock have been revising their EPS expectations upwards in a significant manner.
  • For the past twelve months, EPS forecast has been revised upwards.
  • Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
  • Over the past four months, analysts' average price target has been revised upwards significantly.

Weaknesses
  • In relation to the value of its tangible assets, the company's valuation appears relatively high.
  • The overall consensus opinion of analysts has deteriorated sharply over the past four months.
  • The price targets of various analysts who make up the consensus differ significantly. This reflects different assessments and/or a difficulty in valuing the company.

© MarketScreener.com 2021

Disclaimer: The information, charts, data, views, or comments provided by SURPERFORMANCE SAS are intended for investors who have the necessary knowledge and experience to understand and appreciate the information contained within. These items are disseminated for personal reference only. They do not constitute an offer or solicitation to buy or sell financial products or services, nor an investment advice.
The use of the information disseminated takes place under the investor's sole responsibility, without recourse against SURPERFORMANCE SAS. SURPERFORMANCE SAS will not be liable, whether in contract, in tort, under any warranty, for errors, omissions, improper investments, or adverse evolution of markets.

Financials (USD)
Sales 2021 2 268 M - -
Net income 2021 499 M - -
Net Debt 2021 218 M - -
P/E ratio 2021 16,3x
Yield 2021 -
Capitalization 8 884 M 8 884 M -
EV / Sales 2021 4,01x
EV / Sales 2022 3,50x
Nbr of Employees 4 600
Free-Float 57,7%
Upcoming event on CROCS, INC.
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 8
Last Close Price 142,40 $
Average target price 181,29 $
Spread / Average Target 27,3%
EPS Revisions
Managers and Directors
Andrew Rees Chief Executive Officer & Director
Michelle Poole President
Anne Mehlman Chief Financial Officer & Executive Vice President
Thomas J. Smach Chairman
Michael Feliton Chief Information Officer & Senior Vice President
Sector and Competitors
1st jan.Capi. (M$)
CROCS, INC.128.46%8 930
PUMA SE8.58%17 392
DECKERS OUTDOOR CORPORATION28.17%10 168
DR. MARTENS PLC0.00%5 056
ALPARGATAS S.A.12.67%4 592
RELAXO FOOTWEARS LIMITED66.90%4 517